Evidence map›Paper›PMID 36922997›Full record

ReviewiScience2023

Single-atom catalysts for hydroformylation of olefins.

Shu Tao, Da Yang, Minmin Wang, Guangxun Sun, Gaoyan Xiong, Wenwen Gao, Youzhi Zhang, Yuan Pan

Abstract readReview
In one paragraph

Review in iScience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shu TaoCollege of Chemistry and Chemical Engineering, China University of Petroleum (East China), Qingdao 266580, China.
Da YangCollege of Chemistry and Chemical Engineering, China University of Petroleum (East China), Qingdao 266580, China.
Minmin WangCollege of Chemistry and Chemical Engineering, China University of Petroleum (East China), Qingdao 266580, China.
Guangxun SunCollege of Chemistry and Chemical Engineering, China University of Petroleum (East China), Qingdao 266580, China.
Gaoyan XiongCollege of Chemistry and Chemical Engineering, China University of Petroleum (East China), Qingdao 266580, China.
Wenwen GaoCollege of Chemistry and Chemical Engineering, China University of Petroleum (East China), Qingdao 266580, China.
Youzhi ZhangCollege of Chemistry and Chemical Engineering, China University of Petroleum (East China), Qingdao 266580, China.
Yuan PanCollege of Chemistry and Chemical Engineering, China University of Petroleum (East China), Qingdao 266580, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hydroformylation is one of the most significant homogeneous reactions. Compared with homogeneous catalysts, heterogeneous catalysts are easy to be separated from the system. However, heterogeneous catalysis faces the problems of low activity and poor chemical/regional selectivity. Therefore, there are theoretical and practical significance to develop efficient heterogeneous catalysts. SACs can be widely applied in hydroformylation in the future, due to the high atom utilization efficiency, stable active sites, easy separation, and recovery. In this review, the recent advances of SACs for hydroformylation are summarized. The regulation of microstructure affected on the reactivity, stability of SACs, and chem/regioselectivity of SACs for hydroformylation are discussed. The support effect, ligand effect, and electron effect on the performance of SACs are proposed, and the catalytic mechanism of SACs is elaborated. Finally, we summarize the current challenges in this field, and propose the design and research ideas of SACs for hydroformylation of olefins.

Indexed as

HydroformylationSingle-atom catalysts

Identifiers

PMID36922997
PMCPMC10009200

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.